News

This editorial by Dr. Robert T. Chen first appeared in the October 2023 issue of Safety by Numbers. It is reposted here with permission from[...]

Dear Brighton Collaboration members: Please find below a draft Brighton Collaboration case definition for both TTS (thrombosis and thrombocytopenia syndrome) and VITT (vaccine-induced[...]

This editorial was previously published in Vaccine Safety Quarterly. Karina Top, MD, MS Karina Top, MD, MS | Principal Investigator,[...]

On behalf of the Brighton Collaboration Autoimmune Hepatitis Case Definition Working Group, please find below a manuscript on “Autoimmune hepatitis: Brighton Collaboration case[...]

On behalf of the Brighton Collaboration BRAVATO (Benefit-Risk Assessment of VAccines by TechnolOgy) Working Group, please find enclosed a manuscript and accompanying case[...]

On 8 and 9 November 2022, the Maternal Immunization Working Group (MIWG) held an in-person and online hybrid meeting. The objectives of the[...]

We are updating the Brighton website and need help from frequent users to advance requirements and provide design feedback. We will do this work[...]

The Coalition for Epidemic Preparedness Innovations (CEPI) and the Brighton Collaboration, based in Atlanta at The Task Force for Global Health, announced the expansion of[...]

SPEAC has completed a fifth update to the Priority List of potential Adverse events of special interest relevant to COVID-19 vaccine trials.  Past[...]

We are proud to announce that Dr. Bob Chen, Scientific Director of the Brighton Collaboration, received a special award for “Contributions to Public Health[...]

To help meet its increasing needs, the Secretariat for the Brighton Collaboration (BC) has recently posted a new staff position: Director of Research. The position[...]

Coalition for Epidemic Preparedness Innovations (CEPI) through the Safety Platform for Emergency vACcines (SPEAC) project, has funded the development of a training program for potential[...]